JDRF Blog

State of the Foundation: Inspiring T1D Champions | Accelerating Cures

Read More About State of the Foundation: Inspiring T1D Champions | Accelerating Cures

Join Us "Inside the Lab at Boston"

The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a bit shrouded...

Read More About Join Us "Inside the Lab at Boston"

JDRF Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research

Read More About JDRF Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research

Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019,...

Read More About Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

Recent Articles

  • Thank you for being T1D Champions

    December 3, 2019

    Read more

  • State of the Foundation: Inspiring T1D Champions | Accelerating Cures

    November 20, 2019

    Read more

  • Insulin Affordability Matters: Advocating to Make Insulin More Affordable for All

    November 14, 2019

    More than 1.25 million Americans live with type 1 diabetes (T1D), and this number continues to grow. They need insulin several times...

    Read more

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

    Read more

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

    Read more

  • The Promising Clinical Trials in the JDRF Pipeline

    December 9, 2019

    As the leading global funder of type 1 diabetes (T1D) research, JDRF invests in the most promising research studies across the world—including...

    Read more

  • One Less Device: Combining CGM and Insulin Infusion—JDRF Clinical Trial

    December 9, 2019

    JDRF is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and unreliable, and need...

    Read more

  • Why Does One Scientist Seek Cures for T1D? Answer: Family

    December 3, 2019

    Reza Abdi, M.D., has a reason to care about diabetes research—he has a father and a brother with the disease. Dr. Abdi,...

    Read more

  • JDRF Beta Cell Replacement Consortium: Partnerships and Paradigm Shifts

    November 27, 2019

    Last week’s JDRF Beta Cell Replacement Consortium enabled 57 researchers the chance to collaborate in ways that help move research forward more...

    Read more

  • Production of Insulin in People with Type 1 Diabetes

    November 25, 2019

    Sernova, a clinical-stage regenerative medicine company, has shown in its JDRF-funded clinical trial that its cell replacement therapy, the Cell Pouch System™,...

    Read more